Expression of bone sialoprotein and osteopontin in breast cancer bone metastases

Clinical and Experimental Metastasis

Volumn 18, Issue 3, 2000, Pages 253-260

  Ibrahim, Tharwat ^a   Leong, Iona ^a   Sanchez Sweatman, Otto ^b   Khokha, Rama ^b   Sodek, Jaro ^c   Tenenbaum, Howard C ^a   Ganss, Bernard ^a   Cheifetz, Sela ^a  

^a Medical Research Council Group in Periodontal Physiology   (Canada)

^b PRINCESS MARGARET HOSPITAL   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

Bone metastases; Bone sialoprotein; Breast cancer; Immunohistochemistry; In situ hybridization; Metastasis; Osteopontin

Indexed keywords

OSTEOPONTIN; SIALOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE METASTASIS; BONE REMODELING; BREAST CANCER; CANCER CELL CULTURE; CANCER INFILTRATION; CELL STRAIN MCF 7; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MOUSE; NONHUMAN; NUDE MOUSE; OSTEOBLAST; OSTEOCYTE; OSTEOLYSIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION;

ANIMALS; BONE NEOPLASMS; BREAST NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MICE; MICE, NUDE; OSTEOPONTIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIALOGLYCOPROTEINS; TUMOR CELLS, CULTURED;

EID: 0035058961     PISSN: 02620898     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006754605901     Document Type: Article

References (47)

1. Osteonectin promotes prostate cancer cell migration and invasion. A possible mechanism for metastasis to bone
2. Osteopontin expression and distribution in human carcinomas
3. The role of osteopontin in tumorigenesis and metastasis
4. Increased expression of osteonectin and osteopontin, two bone matrix proteins, in human breast cancer
5. Bone sialoprotein expression in primary human breast cancer is associated with bone metastases development
6. Expression of bone sialoprotein in human lung cancer
7. Expression of bone matrix protein messenger ribonucleic acids in human breast cancers. Possible involvement of osteopontin in development of calcifying foci
8. Calcitonoin receptors, bone sialoprotein and osteopontin are expressed in primary breast tumours
9. Prognostic value of bone sialoprotein expression in clinically localized human prostate cancer
10. Tumor cells are the source of osteopontin and bone sialoprotein expression in human breast cancer
11. The proteins of bone
12. Bone sialoprotein
13. Osteopontin
14. Pathogenesis of bone metastases: Role of tumor-related proteins
15. The primary structure of bone sialoprotein
16. Human bone sialoprotein. Deduced protein sequence and chromosomal localization
17. Developmental expression of bone sialoprotein mRNA in rat mineralized connective tissues
18. Bone sialoprotein is localized to the root surface during cementogenesis
19. Expression of bone sialoprotein, a bone matrix protein, in human breast cancer
20. Expression of bone sialoprotein in primary human breast cancer is associated with poor survival
21. Detection of bone sialoprotein in human breast cancer tissue and cell lines at both protein and messenger ribonucleic acid levels
22. Evidence that breast cancer associated microcalcifications are mineralized malignant cells
23. Bone sialoprotein in serum of patients with malignant bone-diseases
24. Serum bone sialoprotein in patients with primary breast cancer is a prognostic marker for subsequent bone metastasis
25. Elevated plasma osteopontin in metastatic breast cancer associated with increased tumor burden and decreased survival
26. Osteopontin and p53 expression are associated with tumor progression in a case of synchronous, bilateral invasive mammary carcinomas
27. Osteopontin: A protein with diverse functions
28. Overcoming obstacles to metastasis defenses against host defenses: Osteopontin (OPN) as a shield against attack by cytotoxic host cells
29. Distinct roles of osteopontin in host defense activity and tumor survival during squamous cell carcinoma progression in vivo
30. NFkB mediates alphavbeta3 integrin-induced endothelial cell survival
31. Factor H binding to bone sialoprotein and osteopontin enables tumor evasion of complement-mediated attack
32. Inihibition of calcium oxalate crystal growth in vitro by uropontin: Another member of the aspartic acid-rich protein superfamily
33. Antisera and CDNA probes to human and certain animal model bone matrix noncollagenous proteins
34. Increased expression of bone sialoprotein in bone metastases compared to visceral metastases in human breast and prostate cancers
35. Oestrogen receptors, site of metastastic disease and survival in recurrent breast cancer
36. Mechanisms involved in the metastasis of cancer to bone
37. Osteolytic bone disease in breast cancer
38. Expression of bone sialoprotein in mineralized tissues of tooth and bone and in buccal-pouch carcinomas of Syrian golden hamsters
39. Noncollagenous proteins in heterotopic ossification. Immunohistochemical analysis in 15 paraplegics
40. Matrix-mineral relationships in calcifying human atherosclerotic plaque: Ultrastructural immunodetection of osteopontin and bone sialoprotein at calcification sites
41. Matrix proteins with high affinity for calcium ions are associated with mineralization within the elastic fibers of pseudoxanthoma elasticum dermis
42. Nucleation of hydroxyapatite by bone sialoprotein
43. Identification of a bone sialoprotein receptor in osteosarcoma cells
44. Integrins and Cancer
45. Dependence of cyclin E-CDK2 kinase activity on cell anchorage
46. Eta-(osteopontin): An early component of type-1 (cell mediated) immunity
47. Nucleation and inhibition of hydroxyapatite formation by mineralized tissue proteins